Optimal timing of sipuleucel-T treatment in metastatic castration-resistant prostate cancer. [electronic resource]
- The Canadian journal of urology Dec 2015
- 8048-55 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1195-9479
Antineoplastic Agents--administration & dosage Clinical Trials as Topic Humans Immunotherapy Male Neoplasm Metastasis Prostatic Neoplasms, Castration-Resistant--drug therapy Time Factors Tissue Extracts--administration & dosage Tumor Burden